Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
Liucan Wang, Min Yu, Hua Yang Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Min Yu; Hua Yang Tel/Fax +8623-687-55705Email yumimianbao@163.com; huayang@tmmu.edu.cnAbstract: The effective colon drug delivery rem...
Guardado en:
Autores principales: | Wang L, Yu M, Yang H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9dbd1fd62351448e91b339f437c02723 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease
por: Huang Q, et al.
Publicado: (2021) -
Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
por: Cury DB, et al.
Publicado: (2019) -
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara T, et al.
Publicado: (2018) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021) -
Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
por: Al-Meghaiseeb ES, et al.
Publicado: (2016)